期刊
CURRENT OPINION IN CELL BIOLOGY
卷 21, 期 2, 页码 140-146出版社
CURRENT BIOLOGY LTD
DOI: 10.1016/j.ceb.2009.01.028
关键词
-
类别
资金
- NCI NIH HHS [R01 CA082683, R01 CA082683-10] Funding Source: Medline
In the 30 years since its discovery, tyrosine phosphorylation has emerged as a fundamentally important mechanism of signal transduction and regulation in all eukaryotic cells, governing many processes, including cell proliferation, cell cycle progression, metabolic homeostasis, transcriptional activation, neural transmission, differentiation and development, and aging. Perturbations in tyrosine phosphorylation underlie many human diseases, and in particular cancer, and this has prompted the development of inhibitors of tyrosine kinases implicated in disease, a number of which have been approved for clinical use. The following is a brief personal reflection on some of the salient findings over the past 30 years that led to the development of tyrosine kinase inhibitors for disease therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据